ELI LILLY & Co — Director's Dealing 2019

Feb 1, 2019

SEC Form 4/A — Form 4/A

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-04-13

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-16	Common Stock	S	17379	$80.08	Disposed	40685	Direct

Footnotes

F1: This amendment is being filed to correct the total holdings held by the reporting person following the transaction reported on the original Form 4 filed on April 17, 2018.